Eli Lilly & Co. (LLY)
935.58
-18.94
(-1.98%)
USD |
NYSE |
Apr 02, 16:00
935.57
-0.01
(-0.00%)
After-Hours: 20:00
Eli Lilly SG&A Expense (TTM) : 11.09B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Viking Therapeutics, Inc. | 48.39M |
| Apellis Pharmaceuticals, Inc. | 550.26M |
| Arcellx, Inc. | 117.76M |
| Moderna, Inc. | 1.018B |